AU2002217808A1 - Inositol derivatives for increasing chloride secretion and inhibiting inflammation - Google Patents

Inositol derivatives for increasing chloride secretion and inhibiting inflammation

Info

Publication number
AU2002217808A1
AU2002217808A1 AU2002217808A AU1780802A AU2002217808A1 AU 2002217808 A1 AU2002217808 A1 AU 2002217808A1 AU 2002217808 A AU2002217808 A AU 2002217808A AU 1780802 A AU1780802 A AU 1780802A AU 2002217808 A1 AU2002217808 A1 AU 2002217808A1
Authority
AU
Australia
Prior art keywords
inhibiting inflammation
chloride secretion
inositol derivatives
increasing chloride
increasing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002217808A
Other languages
English (en)
Inventor
Tanja Meyerdierks
Mark Moody
Andrew Schnaars
Carsten Schultz
Jane Smith
Alexis Traynor-Kaplan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inologic Inc
Original Assignee
Inologic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inologic Inc filed Critical Inologic Inc
Publication of AU2002217808A1 publication Critical patent/AU2002217808A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • C07F9/65522Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/117Esters of phosphoric acids with cycloaliphatic alcohols
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • C07F9/65517Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65525Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a seven-(or more) membered ring
    • C07F9/65527Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a seven-(or more) membered ring condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2002217808A 2000-11-21 2001-11-21 Inositol derivatives for increasing chloride secretion and inhibiting inflammation Abandoned AU2002217808A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US25260300P 2000-11-21 2000-11-21
US60252603 2000-11-21
US60/252,603 2000-11-21
PCT/US2001/043664 WO2002041831A2 (en) 2000-11-21 2001-11-21 Inositol derivatives for increasing chloride secretion and inhibiting inflammation

Publications (1)

Publication Number Publication Date
AU2002217808A1 true AU2002217808A1 (en) 2002-06-03

Family

ID=22956721

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002217808A Abandoned AU2002217808A1 (en) 2000-11-21 2001-11-21 Inositol derivatives for increasing chloride secretion and inhibiting inflammation

Country Status (6)

Country Link
US (1) US7453006B2 (enExample)
EP (1) EP1345950A4 (enExample)
JP (1) JP2004518639A (enExample)
AU (1) AU2002217808A1 (enExample)
CA (1) CA2430190A1 (enExample)
WO (1) WO2002041831A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2828206B1 (fr) * 2001-08-03 2004-09-24 Centre Nat Rech Scient Utilisation d'inhibiteurs des lysyl oxydases pour la culture cellulaire et le genie tissulaire
AU2002327006A1 (en) * 2001-09-20 2003-04-01 Inologic, Inc. Method of modulating sodium ion absorption in epithelial cells
AU2003231157C1 (en) * 2002-04-29 2009-02-26 Normoxys, Inc. Inositol pyrophosphates, and methods of use thereof
US20060177517A1 (en) * 2003-02-26 2006-08-10 Toshikazu Shiba Antiinflammtory agent and antiinflammatory medical material
US20060258626A1 (en) * 2004-07-06 2006-11-16 Claude Nicolau Use of inositol-tripyrophosphate in treating tumors and diseases
US20060106000A1 (en) * 2004-07-06 2006-05-18 Claude Nicolau Use of inositol-tripyrophosphate in treating tumors and diseases
US7745423B2 (en) * 2004-07-06 2010-06-29 NormOxys, Inc Calcium/sodium salt of inositol tripyrophosphate as an allosteric effector of hemoglobin
PL1863495T3 (pl) * 2005-03-18 2015-06-30 Normoxys Inc Sól wapniowa 1,6:2,3:4,5-tripirofosforanu mioinozytolu jako efektor allosteryczny hemoglobiny w leczeniu raka
AU2006344178A1 (en) * 2006-06-09 2007-12-13 Erasmus University Medical Center Rotterdam Modulation of the immune system by inositol phospholipids
CN101784193A (zh) * 2007-05-01 2010-07-21 诺尔姆奥克西斯公司 促红细胞生成素互补或替代
US8414533B2 (en) 2009-10-08 2013-04-09 Shl Group Ab Medicament delivery device

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8605063D0 (sv) * 1986-11-26 1986-11-26 Matti Siren Derivatives of cyclohexane
FR2694936B1 (fr) * 1992-08-18 1994-11-25 Bayer Pharma Dérivés substitués du désoxy-myoinositol, procédé pour leur préparation et leur utilisation dans des médicaments.
SE503122C2 (sv) * 1993-11-22 1996-03-25 Perstorp Ab Användning av en inositoltrisfosfatester för behandling av inflammatoriska tillstånd
US5977078A (en) * 1996-09-20 1999-11-02 The Regents Of The Univesity Of California Inositol polyphosphate derivatives and methods of using same
AU721150B2 (en) * 1996-09-20 2000-06-22 Inologic, Inc. Inositol polyphosphate derivatives and methods of using same
US6221856B1 (en) * 1999-02-03 2001-04-24 Inologic, Inc. Inositol derivatives for inhibiting superoxide anion production

Also Published As

Publication number Publication date
WO2002041831A3 (en) 2002-07-18
EP1345950A4 (en) 2005-04-27
WO2002041831A2 (en) 2002-05-30
CA2430190A1 (en) 2002-05-30
JP2004518639A (ja) 2004-06-24
US7453006B2 (en) 2008-11-18
EP1345950A2 (en) 2003-09-24
US20040147487A1 (en) 2004-07-29

Similar Documents

Publication Publication Date Title
AU2001258771A1 (en) -secretase inhibitors
AU4677399A (en) Inhibitors of H+K+-ATPase
AU5597300A (en) In-line bi-directional razor devices
AU2001297524A1 (en) Fen endonucleases
AU2002220241A1 (en) Parb inhibitors
AU6474400A (en) Compressor
AU2001268750A1 (en) Flushed-seal respirator
AU2001278558A1 (en) Use of co for treating inflammation of upper airways or bronchi
AU4825300A (en) Methods for inhibiting cutaneous inflammation and hyperpigmentation
AU2002217808A1 (en) Inositol derivatives for increasing chloride secretion and inhibiting inflammation
AU2001248472A1 (en) Compounds derived from LA2MO2O9 and their use as ionic conductors
AU2608301A (en) Methods for inhibiting mastocytosis
AU2001244562A1 (en) Neovascularization inhibitors
AU3235100A (en) Prothease inhibitors
AU7053500A (en) Chymotrypsin-free trypsin
AU7627601A (en) Drug-delivery systems
AU2001275723A1 (en) Bougie
AU2002338989A1 (en) Substituted C-furan-2-yl-methylamine and C-thiophen-2-yl-methylamine derivatives
AU5762899A (en) Caspase inhibitor
AU2001293666A1 (en) Anti-wear protection covering and anti-wear protection plate
AU2001228784A1 (en) Inositol derivatives and their pharmaceutical use
AU2001265200A1 (en) Footwear having visual fitting apparatus
AU3632299A (en) Face mask or bandage
AU2001260045A1 (en) Secure pants
AU2001281116A1 (en) Human serpin zserp15